This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Ferenci P, Fried M, Labrecque D, Bruix J, Sherman M, Omata M, et al. Hepatocellular carcinoma (HCC): a global perspective. J Clin Gastroenterol 2010; 44: 239-45. doi: 10.1097/MCG.0b013e3181d46ef2FerenciPFriedMLabrecqueDBruixJShermanMOmataMet alHepatocellular carcinoma (HCC): a global perspectiveJ Clin Gastroenterol2010442394510.1097/MCG.0b013e3181d46ef220216082Open DOISearch in Google Scholar
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics 2012. CA Cancer J Clin 2015; 65: 87-108. doi: 10.3322/caac.21262TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemal AGlobal cancer statistics2012CA Cancer J Clin2015658710810.3322/caac.2126225651787Open DOISearch in Google Scholar
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin 2018; 68: 7-30. doi: 10.3322/caac.21442SiegelRLMillerKDJemalA.Cancer statistics, 2018CA Cancer J Clin20186873010.3322/caac.2144229313949Open DOISearch in Google Scholar
Tang A, Hallouch O, Chernyak V, Kamaya A, Sirlin CB. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis. Abdom Radiol (NY) 2018; 43: 13-25. doi: 10.1007/s00261-017-1209-1TangAHallouchOChernyakVKamayaASirlinCBEpidemiology of hepatocellular carcinoma: target population for surveillance and diagnosisAbdom Radiol (NY)201843132510.1007/s00261-017-1209-128647765Open DOISearch in Google Scholar
Krinsky GA, Lee VS. MR imaging of cirrhotic nodules. Abdom Imaging 2000; 25: 471-82.KrinskyGALeeVSMR imaging of cirrhotic nodulesAbdom Imaging2000254718210.1007/s00261000001510931980Search in Google Scholar
Nishida N, Goel A. Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review. Curr Genomics 2011; 12: 130-7. doi: 10.2174/138920211795564359NishidaNGoelAGenetic and epigenetic signatures in human hepatocellular carcinoma: a systematic reviewCurr Genomics201112130710.2174/138920211795564359312904721966251Open DOISearch in Google Scholar
Choi JY, Lee JM, Sirlin CB. CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology 2014; 272: 635-54. doi: 10.1148/radiol.14132361.ChoiJYLeeJMSirlinCBCT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspectsRadiology20142726355410.1148/radiol.14132361426363125153274Open DOISearch in Google Scholar
Crissien AM, Frenette C. Current management of hepatocellular carcinoma. Gastroenterol Hepatol (NY) 2014; 10: 153-61. PMCID: PMC4014047CrissienAMFrenetteCCurrent management of hepatocellular carcinomaGastroenterol Hepatol (NY)20141015361PMCID: PMC4014047Search in Google Scholar
European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-43. doi: 10.1016/j.jhep.2011.12.001European Association For The Study Of The Liver, European Organisation For Research And Treatment Of CancerEASL-EORTC clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol2012569084310.1016/j.jhep.2011.12.00122424438Open DOISearch in Google Scholar
Elsayes KM, Hooker JC, Agrons MM, Kielar AZ, Tang A, Fowler KJ, et al. 2017 Version of LI-RADS for CT and MR imaging: an update. Radiographics 2017; 37: 1994-2017. doi: 10.1148/rg.2017170098.ElsayesKMHookerJCAgronsMMKielarAZTangAFowlerKJet al2017Version of LI-RADS for CT and MR imaging: an updateRadiographics2017371994201710.1148/rg.201717009829131761Open DOISearch in Google Scholar
Arif-Tiwari H, Kalb B, Chundru S, Sharma P, Costello J, Guessner RW, et al. MRI of hepatocellular carcinoma: an update of current practices. Diagn Interv Radiol 2014; 20: 209-21. doi: 10.5152/dir.2014.13370.Arif-TiwariHKalbBChundruSSharmaPCostelloJGuessnerRWet alMRI of hepatocellular carcinoma: an update of current practicesDiagn Interv Radiol2014202092110.5152/dir.2014.13370446335124808419Open DOISearch in Google Scholar
Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 2018; 67: 358-80. doi: 10.1002/hep.29086.HeimbachJKKulikLMFinnRSSirlinCBAbecassisMMRobertsLRet alAASLD guidelines for the treatment of hepatocellular carcinomaHepatology2018673588010.1002/hep.2908628130846Open DOISearch in Google Scholar
Wald C, Russo MW, Heimbach JK, Hussain HK, Pomfret EA, Bruix J. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology 2013; 266: 376-82. doi: 10.1148/radiol.12121698WaldCRussoMWHeimbachJKHussainHKPomfretEABruixJNew OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinomaRadiology20132663768210.1148/radiol.1212169823362092Open DOISearch in Google Scholar
Kambadakone AR, Fung A, Gupta RT, et al. LI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasound. Abdom Radiol (NY) 2018; 43: 56-74. doi: 10.1007/s00261-017-1345-7.KambadakoneARFungAGuptaRTet alLI-RADS technical requirements for CT, MRI, and contrast-enhanced ultrasoundAbdom Radiol (NY)201843567410.1007/s00261-017-1345-729098367Open DOISearch in Google Scholar
Le Moigne F, Durieux M, Bancel B, Boublay N, Boussel L, Ducerf C, et al. Impact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liver. Magn Reson Imaging 2012; 30: 656-65. doi: 10.1016/j.mri.2012.01.002Le MoigneFDurieuxMBancelBBoublayNBousselLDucerfCet alImpact of diffusion-weighted MR imaging on the characterization of small hepatocellular carcinoma in the cirrhotic liverMagn Reson Imaging2012306566510.1016/j.mri.2012.01.00222459435Open DOISearch in Google Scholar
Mannelli L, Nougaret S, Vargas HA, Do RK. Advances in diffusion-weighted imaging. Radiol Clin North Am 2015; 53: 569-81. doi: 10.1016/j. rcl.2015.01.002MannelliLNougaretSVargasHADoRKAdvances in diffusion-weighted imagingRadiol Clin North Am2015535698110.1016/j.rcl.2015.01.002497931825953290Open DOISearch in Google Scholar
Mannelli L, Bhargava P, Osman SF, Raz E, Moshiri M, Laffi G, et al. Diffusion-weighted imaging of the liver: a comprehensive review. Curr Probl Diagn Radiol 2013; 42: 77-83. doi: 10.1067/j.cpradiol.2012.07.001MannelliLBhargavaPOsmanSFRazEMoshiriMLaffiGet alDiffusion-weighted imaging of the liver: a comprehensive reviewCurr Probl Diagn Radiol201342778310.1067/j.cpradiol.2012.07.00123683849Open DOISearch in Google Scholar
Horvat N, Nikolovski I, Long N, Gerst S, Zheng J, Pak LM, et al. Imaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version 2014. Abdom Radiol (NY) 2018; 43: 169-78. doi: 10.1007/s00261-017-1261-xHorvatNNikolovskiILongNGerstSZhengJPakLMet alImaging features of hepatocellular carcinoma compared to intrahepatic cholangiocarcinoma and combined tumor on MRI using liver imaging and data system (LI-RADS) version2014Abdom Radiol (NY)2018431697810.1007/s00261-017-1261-x659868528765978Open DOISearch in Google Scholar
Mannelli L, Kim S, Hajdu CH, Babb JS, Taouli B. Serial diffusion-weighted MRI in patients with hepatocellular carcinoma: prediction and assessment of response to transarterial chemoembolization. Preliminary experience. Eur J Radiol 2013; 82: 577-82. doi: 10.1016/j.ejrad.2012.11.026MannelliLKimSHajduCHBabbJSTaouliBSerial diffusion-weighted MRI in patients with hepatocellular carcinoma: prediction and assessment of response to transarterial chemoembolization. Preliminary experienceEur J Radiol2013825778210.1016/j.ejrad.2012.11.02623246330Open DOISearch in Google Scholar
Chegai F, Merolla S, Greco L, Nezzo M, Mannelli L, Orlacchio A. Re: Baseline and early MR apparent diffusion coefficient quantification as a predictor of response of unresectable hepatocellular carcinoma to doxorubicin drug-eluting bead chemoembolization. J Vasc Interv Radiol 2016; 27: 1456-8. doi: 10.1016/j.jvir.2016.05.007ChegaiFMerollaSGrecoLNezzoMMannelliLOrlacchioARe: Baseline and early MR apparent diffusion coefficient quantification as a predictor of response of unresectable hepatocellular carcinoma to doxorubicin drug-eluting bead chemoembolizationJ Vasc Interv Radiol2016271456810.1016/j.jvir.2016.05.007554045427566431Open DOISearch in Google Scholar
Gluskin JS, Chegai F, Monti S, Squillaci E, Mannelli L. Hepatocellular carcinoma and diffusion-weighted MRI: detection and evaluation of treatment response. J Cancer 2016; 7: 1565-70. doi: 10.7150/jca.14582GluskinJSChegaiFMontiSSquillaciEMannelliLHepatocellular carcinoma and diffusion-weighted MRI: detection and evaluation of treatment responseJ Cancer2016715657010.7150/jca.14582496414127471573Open DOISearch in Google Scholar
Park MS, Kim S, Patel J, Hajdu CH, Do RK, Mannelli L, et al. Hepatocellular carcinoma: detection with diffusion-weighted versus contrast-enhanced magnetic resonance imaging in pretransplant patients. Hepatology 2012; 56: 140-8. doi: 10.1002/hep.25681ParkMSKimSPatelJHajduCHDoRKMannelliLet alHepatocellular carcinoma: detection with diffusion-weighted versus contrast-enhanced magnetic resonance imaging in pretransplant patientsHepatology201256140810.1002/hep.2568122370974Open DOISearch in Google Scholar
Agostini A, Kircher MF, Do R, Borgheresi A, Monti S, Giovagnoni A, et al. Magnetic resonance imaging of the liver (including biliary contrast agents) part 1: technical considerations and contrast materials. Semin Roentgenol 2016; 51: 308-16. doi: 10.1053/j.ro.2016.05.015AgostiniAKircherMFDoRBorgheresiAMontiSGiovagnoniAet alMagnetic resonance imaging of the liver (including biliary contrast agents) part 1: technical considerations and contrast materialsSemin Roentgenol2016513081610.1053/j.ro.2016.05.015551508527743567Open DOISearch in Google Scholar
Ramalho J, Ramalho M. Gadolinium deposition and chronic toxicity. Magn Reson Imaging Clin N Am 2017; 25: 765-78. doi: 10.1016/j.mric.2017.06.007RamalhoJRamalhoMGadolinium deposition and chronic toxicityMagn Reson Imaging Clin N Am2017257657810.1016/j.mric.2017.06.00728964466Open DOISearch in Google Scholar
Hernando D, Levin YS, Sirlin CB, Reeder SB. Quantification of liver iron with MRI: state of the art and remaining challenges. J Magn Reson Imaging 2014; 40: 1003-21. doi: 10.1002/jmri.24584HernandoDLevinYSSirlinCBReederSBQuantification of liver iron with MRI: state of the art and remaining challengesJ Magn Reson Imaging20144010032110.1002/jmri.24584430874024585403Open DOISearch in Google Scholar
Agostini A, Kircher MF, Do RK, Borgheresi A, Monti S, Giovagnoni A. Magnetic resonanance imaging of the liver (including biliary contrast agents) part 2: protocols for liver magnetic resonanance imaging and characterization of common focal liver lesions. Semin Roentgenol 2016; 51: 317-33. doi: 10.1053/j.ro.2016.05.016AgostiniAKircherMFDoRKBorgheresiAMontiSGiovagnoniAMagnetic resonanance imaging of the liver (including biliary contrast agents) part 2: protocols for liver magnetic resonanance imaging and characterization of common focal liver lesionsSemin Roentgenol2016513173310.1053/j.ro.2016.05.016511743227743568Open DOISearch in Google Scholar
Liu D, Song B, Huang ZX, Wu B, Tang HH. [The iron content of hepatocellular carcinoma associated nodules: study of histopathology and MR imaging]. [Chinese]. Sichuan Da Xue Xue Bao Yi Xue Ban 2016; 47: 376-81. PMID: 27468484LiuDSongBHuangZXWuBTangHH[The iron content of hepatocellular carcinoma associated nodules: study of histopathology and MR imaging][Chinese]Sichuan Da Xue Xue Bao Yi Xue Ban20164737681PMID: 27468484Search in Google Scholar
Siripongsakun S, Lee JK, Raman SS, Tong MJ, Sayre J, Lu DS. MRI detection of intratumoral fat in hepatocellular carcinoma: potential biomarker for a more favorable prognosis. AJR Am J Roentgenol 2012; 199: 1018-25. doi: 10.2214/AJR.12.8632SiripongsakunSLeeJKRamanSSTongMJSayreJLuDSMRI detection of intratumoral fat in hepatocellular carcinoma: potential biomarker for a more favorable prognosisAJR Am J Roentgenol201219910182510.2214/AJR.12.863223096174Open DOISearch in Google Scholar
Singh S, Venkatesh SK, Loomba R, Wang Z, Sirlin C, Chen J, et al. Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol 2016; 26: 1431-40. doi: 10.1007/s00330-015-3949-zSinghSVenkateshSKLoombaRWangZSirlinCChenJet alMagnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysisEur Radiol20162614314010.1007/s00330-015-3949-z505126726314479Open DOISearch in Google Scholar
Thompson SM, Wang J, Chandan VS, Glaser KJ, Roberts LR, Ehman RL, et al. MR elastography of hepatocellular carcinoma: correlation of tumor stiffness with histopathology features-preliminary findings. Magn Reson Imaging 2017; 37: 41-5. doi: 10.1016/j.mri.2016.11.005ThompsonSMWangJChandanVSGlaserKJRobertsLREhmanRLet alMR elastography of hepatocellular carcinoma: correlation of tumor stiffness with histopathology features-preliminary findingsMagn Reson Imaging20173741510.1016/j.mri.2016.11.005558712027845245Open DOISearch in Google Scholar
Gordic S, Ayache JB, Kennedy P, Besa C, Wagner M, Bane O, et al. Value of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapy. Abdom Radiol (NY) 2017; 42: 1685-94. doi: 10.1007/s00261-017-1066-yGordicSAyacheJBKennedyPBesaCWagnerMBaneOet alValue of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapyAbdom Radiol (NY)20174216859410.1007/s00261-017-1066-y559063128154910Open DOISearch in Google Scholar
Hanna RF, Aguirre DA, Kased N, Emery SC, Peterson MR, Sirlin CB. Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics 2008; 28: 747-69. doi: 10.1148/rg.283055108HannaRFAguirreDAKasedNEmerySCPetersonMRSirlinCBCirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging featuresRadiographics2008287476910.1148/rg.28305510818480482Open DOISearch in Google Scholar
Efremidis SC, Hytiroglou P. The multistep process of hepatocarcinogenesis in cirrhosis with imaging correlation. Eur Radiol 2002; 12: 753-64. doi: 10.1007/s00330-001-1142-zEfremidisSCHytiroglouPThe multistep process of hepatocarcinogenesis in cirrhosis with imaging correlationEur Radiol2002127536410.1007/s00330-001-1142-z11960222Open DOISearch in Google Scholar
Efremidis SC, Hytiroglou P, Matsui O. Enhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challenges. Eur Radiol 2007; 17: 2969-82. doi: 10.1007/s00330-007-0705-zEfremidisSCHytiroglouPMatsuiOEnhancement patterns and signal-intensity characteristics of small hepatocellular carcinoma in cirrhosis: pathologic basis and diagnostic challengesEur Radiol20071729698210.1007/s00330-007-0705-z17618439Open DOISearch in Google Scholar
Jeong YY, Yim NY, Kang HK. Hepatocellular carcinoma in the cirrhotic liver with helical CT and MRI: imaging spectrum and pitfalls of cirrhosis-related nodules. AJR Am J Roentgenol 2005; 185: 1024-32. doi: 10.2214/AJR.04.1096JeongYYYimNYKangHKHepatocellular carcinoma in the cirrhotic liver with helical CT and MRI: imaging spectrum and pitfalls of cirrhosis-related nodulesAJR Am J Roentgenol200518510243210.2214/AJR.04.109616177427Open DOISearch in Google Scholar
Sadek AG, Mitchell DG, Siegelman ES, Outwater EK, Matteucci T, Hann HW. Early hepatocellular carcinoma that develops within macroregenerative nodules: growth rate depicted at serial MR imaging. Radiology 1995; 195753-6. doi: 10.1148/radiology.195.3.7754006SadekAGMitchellDGSiegelmanESOutwaterEKMatteucciTHannHWEarly hepatocellular carcinoma that develops within macroregenerative nodules: growth rate depicted at serial MR imagingRadiology1995195753-6. doi10.1148/radiology.195.3.77540067754006Open DOISearch in Google Scholar
Willatt JM, Hussain HK, Adusumilli S, Marrero JA. MR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversies. Radiology 2008; 247: 311-30. doi: 10.1148/radiol.2472061331WillattJMHussainHKAdusumilliSMarreroJAMR Imaging of hepatocellular carcinoma in the cirrhotic liver: challenges and controversiesRadiology20082473113010.1148/radiol.247206133118430871Open DOISearch in Google Scholar
Roumanis PS, Bhargava P, Kimia Aubin G, Choi JI, Demirjian AN, Thayer DA, et al. Atypical magnetic resonance imaging findings in hepatocellular carcinoma. Curr Probl Diagn Radiol 2015; 44: 237-45. doi: 10.1067/j.cpra-diol.2014.03.002RoumanisPSBhargavaPKimiaAubin GChoiJIDemirjianANThayerDAet alAtypical magnetic resonance imaging findings in hepatocellular carcinomaCurr Probl Diagn Radiol2015442374510.1067/j.cpra-diol.2014.03.002Open DOISearch in Google Scholar
Mannelli L, Hoang MV, Sabath AP, Linnau KF. An unusual oral mass. Gastroenterology 2012; 142: e14-5. org/10.1053/j.gastro.2011.08047MannelliLHoangMVSabathAPLinnauKFAn unusual oral massGastroenterology2012142e145org/10.1053/j.gastro.2011.08047Open DOISearch in Google Scholar
Trevisani F, Frigerio M, Santi V, Grignaschi A, Bernardi M. Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. Dig Liver Dis 2010; 42: 341-7. doi: 10.1016/j.dld.2009.09.002TrevisaniFFrigerioMSantiVGrignaschiABernardiMHepatocellular carcinoma in non-cirrhotic liver: a reappraisalDig Liver Dis201042341710.1016/j.dld.2009.09.00219828388Open DOISearch in Google Scholar
Potretzke TA, Tan BR, Doyle MB, Brunt EM, Heiken JP, Fowler KJ. Imaging features of biphenotypic primary liver carcinoma (hepatocholangiocarcinoma) and the potential to mimic hepatocellular carcinoma: LI-RADS analysis of CT and MRI features in 61 cases. AJR Am J Roentgenol 2016 207: 25-31. doi: 10.2214/AJR.15.14997PotretzkeTATanBRDoyleMBBruntEMHeikenJPFowlerKJImaging features of biphenotypic primary liver carcinoma (hepatocholangiocarcinoma) and the potential to mimic hepatocellular carcinoma: LI-RADS analysis of CT and MRI features in 61 casesAJR Am J Roentgenol2016207253110.2214/AJR.15.1499726866746Open DOISearch in Google Scholar
Maximin S, Ganeshan DM, Shanbhogue AK, Dighe MK, Yeh MM, Kolokythas O, et al. Current update on combined hepatocellular-cholangiocarcinoma. Eur J Radiol Open 2014; 1: 40-8. doi: 10.1016/j.ejro.2014.07.001MaximinSGaneshanDMShanbhogueAKDigheMKYehMMKolokythasOet alCurrent update on combined hepatocellular-cholangiocarcinomaEur J Radiol Open2014140810.1016/j.ejro.2014.07.001475056626937426Open DOISearch in Google Scholar
Mannelli L, Monti S, Grieco V, Matesan M. Hepatic lesions in a cirrhotic liver: primary or metastases? J Nucl Med Technol 2017; 45: 50-2. doi: 10.2967/jnmt.116.183228.MannelliLMontiSGriecoVMatesanMHepatic lesions in a cirrhotic liver: primary or metastases?J Nucl Med Technol20174550210.2967/jnmt.116.183228694510628154018Open DOISearch in Google Scholar
Khosa F, Khan AN, Eisenberg RL. Hypervascular liver lesions on MRI. AJR Am J Roentgenol 2011; 197: W204-20. doi: 10.2214/AJR.10.5382KhosaFKhanANEisenbergRLHypervascular liver lesions on MRIAJR Am J Roentgenol2011197W2042010.2214/AJR.10.538221785044Open DOISearch in Google Scholar
Ayuso C, Rimola J, Garcia-Criado A. Imaging of HCC. Abdom Imaging 2012; 37: 215-30. doi: 10.1007/s00261-011-9794-xAyusoCRimolaJGarcia-CriadoAImaging of HCCAbdom Imaging2012372153010.1007/s00261-011-9794-x21909721Open DOISearch in Google Scholar
Mannelli L, Kim S, Hajdu CH, Babb JS, Clark TW, Taouli B. Assessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liver. AJR Am J Roentgenol 2009; 193: 1044-52. doi: 10.2214/AJR.08.1461MannelliLKimSHajduCHBabbJSClarkTWTaouliBAssessment of tumor necrosis of hepatocellular carcinoma after chemoembolization: diffusion-weighted and contrast-enhanced MRI with histopathologic correlation of the explanted liverAJR Am J Roentgenol200919310445210.2214/AJR.08.146119770328Open DOISearch in Google Scholar
Colli A, Fraquelli M, Casazza G, Massironi S, Colucci A, Conte D, et al. Accuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic review. Am J Gastroenterol 2006; 101: 513-23. doi: 10.1111/j.1572-0241.2006.00467.xColliAFraquelliMCasazzaGMassironiSColucciAConteDet alAccuracy of ultrasonography, spiral CT, magnetic resonance, and alpha-fetoprotein in diagnosing hepatocellular carcinoma: a systematic reviewAm J Gastroenterol20061015132310.1111/j.1572-0241.2006.00467.x16542288Open DOISearch in Google Scholar
Becker-Weidman DJ, Kalb B, Sharma P, Kitajima HD, Lurie CR, Chen Z, et al. Hepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging-comparison to prior same-center results after MR systems improvements. Radiology 2011; 261: 824-33. doi: 10.1148/radiol.11110157Becker-WeidmanDJKalbBSharmaPKitajimaHDLurieCRChenZet alHepatocellular carcinoma lesion characterization: single-institution clinical performance review of multiphase gadolinium-enhanced MR imaging-comparison to prior same-center results after MR systems improvementsRadiology20112618243310.1148/radiol.1111015721969663Open DOISearch in Google Scholar
Krinsky GA, Lee VS, Theise ND, Weinreb JC, Morgan GR, Diflo T, et al. Transplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imaging. Liver Transpl 2002; 8: 1156-64. doi: 10.1053/jlts.2002.35670KrinskyGALeeVSTheiseNDWeinrebJCMorganGRDifloTet alTransplantation for hepatocellular carcinoma and cirrhosis: sensitivity of magnetic resonance imagingLiver Transpl2002811566410.1053/jlts.2002.3567012474156Open DOISearch in Google Scholar
Burrel M, Llovet JM, Ayuso C, Iglesias C, Sala M, Miquel R, et al. MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation. Hepatology 2003; 38: 1034-42. doi: 10.1053/jhep.2003.50409BurrelMLlovetJMAyusoCIglesiasCSalaMMiquelRet alMRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlationHepatology20033810344210.1053/jhep.2003.5040914512891Open DOISearch in Google Scholar
Lee YJ, Lee JM, Lee JS, Lee HY, Park BH, Kim YH, et al. Hepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysis. Radiology 2015; 275: 97-109. doi: 10.1148/radiol.14140690LeeYJLeeJMLeeJSLeeHYParkBHKimYHet alHepatocellular carcinoma: diagnostic performance of multidetector CT and MR imaging-a systematic review and meta-analysisRadiology20152759710910.1148/radiol.1414069025559230Open DOISearch in Google Scholar
Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008; 47: 97-104. doi: 10.1002/hep.21966FornerAVilanaRAyusoCBianchiLSoléMAyusoJRet alDiagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinomaHepatology2008479710410.1002/hep.2196618069697Open DOISearch in Google Scholar
Chou R, Cuevas C, Fu R, Devine B, Wasson N, Ginsburg A, et al. Imaging techniques for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Ann Intern Med 2015; 162: 697-711. doi: 10.7326/M14-2509ChouRCuevasCFuRDevineBWassonNGinsburgAet alImaging techniques for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysisAnn Intern Med201516269771110.7326/M14-250925984845Open DOISearch in Google Scholar
Xu PJ, Yan FH, Wang JH, Shan Y, Ji Y, Chen CZ. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver. J Comput Assist Tomogr 2010; 34: 506-12. doi: 10.1097/RCT.0b013e3181da3671XuPJYanFHWangJHShanYJiYChenCZContribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liverJ Comput Assist Tomogr2010345061210.1097/RCT.0b013e3181da367120657216Open DOISearch in Google Scholar
Kierans AS, Kang SK, Rosenkrantz AB. The diagnostic performance of dynamic contrast-enhanced MR imaging for detection of small hepatocellular carcinoma measuring up to 2 cm: a meta-analysis. Radiology 2016; 278: 82-94. doi: 10.1148/radiol.2015150177KieransASKangSKRosenkrantzABThe diagnostic performance of dynamic contrast-enhanced MR imaging for detection of small hepatocellular carcinoma measuring up to 2 cm: a meta-analysisRadiology2016278829410.1148/radiol.201515017726098460Open DOISearch in Google Scholar
Ward J, Guthrie JA, Scott DJ, Atchley J, Wilson D, Davies MH, et al. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology 2000; 216: 154-62. doi: 10.1148/radiology.216.1.r00jl24154WardJGuthrieJAScottDJAtchleyJWilsonDDaviesMHet alHepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosisRadiology20002161546210.1148/radiology.216.1.r00jl2415410887242Open DOISearch in Google Scholar
Lu DS, Yu NC, Raman SS, Limanond P, Lassman C, Murray K, et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 2005; 234: 954-60. doi: 10.1148/radiol.2343040153LuDSYuNCRamanSSLimanondPLassmanCMurrayKet alRadiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liverRadiology20052349546010.1148/radiol.234304015315681691Open DOISearch in Google Scholar
Buscarini L, Buscarini E, Di Stasi M, Vallisa D, Quaretti P, Rocca A. Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term results. Eur Radiol 2001; 11: 914-21. doi: 10.1007/s003300000659BuscariniLBuscariniEDi StasiMVallisaDQuarettiPRoccaA.Percutaneous radiofrequency ablation of small hepatocellular carcinoma: long-term resultsEur Radiol2001119142110.1007/s00330000065911419162Open DOISearch in Google Scholar
Kuo MD, Gollub J, Sirlin CB, Ooi C, Chen X. Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma. J Vasc Interv Radiol 2007; 18: 821-31. doi: 10.1016/j.jvir.2007.04.031KuoMDGollubJSirlinCBOoiCChenXRadiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinomaJ Vasc Interv Radiol2007188213110.1016/j.jvir.2007.04.03117609439Open DOISearch in Google Scholar
Jadvar H, Colletti PM. Competitive advantage of PET/MRI. Eur J Radiol 2014; 83: 84-94. doi: 10.1016/j.ejrad.2013.05.028JadvarHCollettiPMCompetitive advantage of PET/MRIEur J Radiol201483849410.1016/j.ejrad.2013.05.028380021623791129Open DOISearch in Google Scholar
Kong E, Chun KA, Cho IH. Quantitative assessment of simultaneous F-18 FDG PET/MRI in patients with various types of hepatic tumors: correlation between glucose metabolism and apparent diffusion coefficient. PLoS One 2017; 12: e0180184. doi: 10.1371/journal.pone.0180184KongEChunKAChoIHQuantitative assessment of simultaneous F-18 FDG PET/MRI in patients with various types of hepatic tumors: correlation between glucose metabolism and apparent diffusion coefficientPLoS One201712e018018410.1371/journal.pone.0180184549533428672016Open DOISearch in Google Scholar
Sun L, Wu H, Guan YS. Positron emission tomography/computer tomography: challenge to conventional imaging modalities in evaluating primary and metastatic liver malignancies. World J Gastroenterol 2007; 13: 2775-83.SunLWuHGuanYSPositron emission tomography/computer tomography: challenge to conventional imaging modalities in evaluating primary and metastatic liver malignanciesWorld J Gastroenterol20071327758310.3748/wjg.v13.i20.2775439562717569111Search in Google Scholar
Talbot JN, Gutman F, Fartoux L, Grange JD, Ganne N, Kerrou K, et al. PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT. Eur J Nucl Med Mol Imaging 2006; 33: 1285-9. doi: 10.1007/s00259-006-0164-9TalbotJNGutmanFFartouxLGrangeJDGanneNKerrouKet alPET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CTEur J Nucl Med Mol Imaging2006331285910.1007/s00259-006-0164-916802155Open DOISearch in Google Scholar
Mertens K, Slaets D, Lambert B, Acou M, De Vos F, Goethals I. PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literature. Eur J Nucl Med Mol Imaging 2010; 37: 2188-93. doi: 10.1007/s00259-010-1496-zMertensKSlaetsDLambertBAcouMDe VosFGoethalsI.PET with (18)F-labelled choline-based tracers for tumour imaging: a review of the literatureEur J Nucl Med Mol Imaging20103721889310.1007/s00259-010-1496-z20544193Open DOISearch in Google Scholar
Yang SH, Suh KS, Lee HW, et al. The role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patients. Liver Transpl 2006; 12: 1655-60. doi: 10.1002/lt.20861YangSHSuhKSLeeHWet alThe role of (18)F-FDG-PET imaging for the selection of liver transplantation candidates among hepatocellular carcinoma patientsLiver Transpl20061216556010.1002/lt.2086116964589Open DOISearch in Google Scholar
Bertagna F, Bertoli M, Bosio G, Biasiotto G, Sadeghi R, Giubbini R, et al. Diagnostic role of radiolabelled choline PET or PET/CT in hepatocellular carcinoma: a systematic review and meta-analysis. Hepatol Int 2014; 8: 493-500. doi: 10.1007/s12072-014-9566-0BertagnaFBertoliMBosioGBiasiottoGSadeghiRGiubbiniRet alDiagnostic role of radiolabelled choline PET or PET/CT in hepatocellular carcinoma: a systematic review and meta-analysisHepatol Int2014849350010.1007/s12072-014-9566-026202754Open DOISearch in Google Scholar
Ho CL, Chen S, Yeung DW, Cheng TK. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma. J Nucl Med 2007; 48: 902-9. doi: 10.2967/jnumed.106.036673HoCLChenSYeungDWChengTKDual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinomaJ Nucl Med200748902910.2967/jnumed.106.03667317504862Open DOISearch in Google Scholar
Castilla-Lièvre MA, Franco D, Gervais P, Kuhnast B, Agostini H, Marthey L, et al. Diagnostic value of combining 11C-choline and 18F-FDG PET/CT in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging 2016; 43: 852-9. doi: 10.1007/s00259-015-3241-0Castilla-LièvreMAFrancoDGervaisPKuhnastBAgostiniHMartheyLet alDiagnostic value of combining 11C-choline and 18F-FDG PET/CT in hepatocellular carcinomaEur J Nucl Med Mol Imaging201643852910.1007/s00259-015-3241-026577938Open DOISearch in Google Scholar
Shao GL, Zheng JP, Guo LW, Chen YT, Zeng H, Yao Z. Evaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging: A prospective study. Medicine (Baltimore) 2017; 96: e5518. doi: 10.1097/MD.0000000000005518ShaoGLZhengJPGuoLWChenYTZengHYaoZEvaluation of efficacy of transcatheter arterial chemoembolization combined with computed tomography-guided radiofrequency ablation for hepatocellular carcinoma using magnetic resonance diffusion weighted imaging and computed tomography perfusion imaging: A prospective studyMedicine (Baltimore)201796e551810.1097/MD.0000000000005518527907428099329Open DOISearch in Google Scholar
Chen X, Xiao E, Shu D, Yang C, Liang B, He Z, et al. Evaluating the therapeutic effect of hepatocellular carcinoma treated with transcatheter arterial chemoembolization by magnetic resonance perfusion imaging. Eur J Gastroenterol Hepatol 2014; 26: 109-13. doi: 10.1097/MEG.0b013e328363716eChenXXiaoEShuDYangCLiangBHeZet alEvaluating the therapeutic effect of hepatocellular carcinoma treated with transcatheter arterial chemoembolization by magnetic resonance perfusion imagingEur J Gastroenterol Hepatol2014261091310.1097/MEG.0b013e328363716e24284371Open DOISearch in Google Scholar
Bayle M, Clerc-Urmès I, Ayav A, Bronowicki JP, Petit I, Orry X, et al. Computed tomographic perfusion with 160-mm coverage: comparative analysis of hepatocellular carcinoma treated by two transarterial chemoembolization courses relative to magnetic resonance imaging findings. Abdom Radiol (NY) 2018. doi: 10.1007/s00261-018-1714-xBayleMClerc-UrmèsIAyavABronowickiJPPetitIOrryXet alComputed tomographic perfusion with 160-mm coverage: comparative analysis of hepatocellular carcinoma treated by two transarterial chemoembolization courses relative to magnetic resonance imaging findingsAbdom Radiol (NY)201810.1007/s00261-018-1714-x30054686Open DOISearch in Google Scholar
